Franzetti F, Cavalli G, Foppa C U, Amprimo M C, Gaido P, Lazzarin A
Clinic of Infectious Disease, Hosp. L.Sacco, University of Milano, Italy.
J Clin Lab Immunol. 1988 Nov;27(3):133-7.
Serum beta 2 microglobulin (beta 2-M) levels were determined in patients with Acquired Immunodeficiency Syndrome (AIDS), AIDS Related Complex (ARC), Persistent Generalized Lymphadenopathy (PGL), healthy intravenous drug addicts (IVDA) and heterosexual controls. Seventy-eight out of 79 AIDS patients (98.7%) exhibited elevated beta 2-M levels. High levels of beta 2-M were also found in 83 of 100 (83%) of PGL/ARC patients and in 24 of 56 (42.8%) healthy IVDA. Patients with AIDS had significantly higher mean beta 2-M levels when compared with all other groups. The mean levels of PGL/ARC patients were significantly higher than those of healthy IVDA and the mean levels for healthy IVDA significantly differ from those of the heterosexual controls. After 2-24 months of follow up three out of four PGL/ARC patients whose serum beta 2-M was greater than 8.0 mg/l developed AIDS.
对获得性免疫缺陷综合征(AIDS)患者、艾滋病相关综合征(ARC)患者、持续性全身性淋巴结病(PGL)患者、健康静脉注射吸毒者(IVDA)以及异性恋对照者测定了血清β2微球蛋白(β2-M)水平。79例AIDS患者中有78例(98.7%)β2-M水平升高。100例PGL/ARC患者中有83例(83%)以及56例健康IVDA中有24例(42.8%)也发现β2-M水平较高。与所有其他组相比,AIDS患者的平均β2-M水平显著更高。PGL/ARC患者的平均水平显著高于健康IVDA,且健康IVDA的平均水平与异性恋对照者的平均水平有显著差异。经过2至24个月的随访,血清β2-M大于8.0mg/L的4例PGL/ARC患者中有3例发展为AIDS。